Arvinas (ARVN)
(Delayed Data from NSDQ)
$26.16 USD
+0.12 (0.46%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $26.15 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 32% (81 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.22 | 1.37 | 9.99 |
Current Quarter Estimate | -0.88 | 2.92 | 61.00 |
Year Ago Quarter Estimate | -1.18 | -4.86 | 54.84 |
Next Quarter Estimate | -0.97 | 3.90 | 63.00 |
Next Year Estimate | -4.20 | 25.15 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 46.98 | 18.00 | 15.67 |
Next Year | -19.66 | 9.30 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 21.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.80 |
Price/Book (MRQ) | 2.99 | 2.09 |
Price/Cash Flow (MRFY) | NA | 17.39 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -147.72% |
Return on Equity (TTM) | -55.59% | -60.38% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.